Candida dubliniensis infections in a pediatric population: Retrospective identification from clinical laboratory isolates of Candida albicans

Journal of Clinical Microbiology

Volumn 41, Issue 7, 2003, Pages 3354-3357

  Kim, Jean O ^a,c   Garofalo, Lucille ^b   Blecker Shelly, Deborah ^b   McGowan, Karin L ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Department of Pediatric Pathology   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; ITRACONAZOLE; MEROPENEM; METRONIDAZOLE; OXACILLIN; SULBACTAM; SULFAMETHOXAZOLE; TICARCILLIN; TOBRAMYCIN; TRIMETHOPRIM; VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; CANDIDA DUBLINIENSIS; CANDIDIASIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE DEFICIENCY; LABORATORY TEST; MALE; NEWBORN; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; RESPIRATORY SYSTEM; RETROSPECTIVE STUDY; TONGUE; VAGINA;

ADOLESCENT; ADULT; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CULTURE MEDIA; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0038167375     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.7.3354-3357.2003     Document Type: Article

References (20)

1. Brandt, M. E., L. H. Harrison, M. Pass, A. N. Sofair, S. Huie, R. K. Li, C. J. Morrison, D. W. Warnock, and R. A. Hajjeh. 2000. Candida dubliniensis fungemia: the first four cases in North America. Emerg. Infect. Dis. 6:46-49.
2. Brown, D. M., M. A. Jabra-Rizk, W. A. Falkler, Jr, A. A. Baqui, and T. F. Meiller. 2000. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients. Pediatr. Dent. 22:234-238.
3. Cimolai, N., J. Davis, and C. Trombley. 2002. Candida dubliniensis fungemia and vascular access infection. J. Pediatr. Hematol. Oncol. 24:237-239.
4. Coleman, D. C., M. G. Rinaldi, K. A. Haynes, J. H. Rex, R. C. Summerbell, E. J. Anaissie, A Li, and D. J. Sullivan. 1998. Importance of Candida species other than Candida albicans as opportunistic pathogens. Med. Mycol. 36(Suppl. 1):156-165.
5. Coleman, D. C., D. J. Sullivan, D. E. Bennett, G. P. Moran, H. J. Barry, and D. B. Shanky. 1997. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 11:557-567.
6. Jabra-Rizk, M. A., A. A. Baqui, J. I. Kelley, W. A. Falkler, Jr., W. G. Merz, and T. F. Meiller. 1999. Identification of Candida dubliniensis in a prospective study of patients in the United States. J. Clin. Microbiol. 37:321-326.
7. Jabra-Rizk, M. A., W. A. Falkler, Jr, W. G. Merz, A. A. Baqui, J. I. Kelley, and T. F. Meiller. 2000. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals. J. Clin. Microbiol. 38:2423-2426.
8. Kirkpatrick, W. R., S. G. Revankar, R. K. Mcatee, J. L. Lopez-Ribot, A. W. Fothergill, D. I. McCarthy, S. E. Sanche, R. A. Cantu, M. G. Rinaldi, and T. F. Patterson. 1998. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J. Clin. Microbiol. 36:3007-3012.
9. Meis, J., M. Ruhnke, B. De Pauw, F. Odds, W. Seigert, and P. Verweij. 1999. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg. Infect. Dis. 5:150-153.
10. Moran, G. P. D. D. Sanglard, S. M. Donnelly, D. Shanley, D. J. Sullivan, and D. C. Coleman. 1998. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 42:1819-1830.
11. Moran, G. P. D., D. J. Sullivan, M. C. Henman, C. E. McCreary, B. J. Harrington, D. B. Shanley, and D. C. Coleman. 1997. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistance derivatives in vitro. Antimicrob. Agents Chemother. 41:617-623.
12. Odds, F. C., L Van Nuffel, and G. Dams. 1998. Prevalence of Candida dubliniensis isolates in a yeast stock collection. J. Clin. Microbiol. 36:2869-2873.
13. Peltroche-Llacsahuanga, H., H. Döhmen, and G. Haase. 2002. Recovery of Candida dubliniensis from sputum of cystic fibrosis patients. Mycoses 45:15-18.
14. Salkin, I. F., W. R. Pruitt, A. A. Padhye, D. Sullivan, D. Coleman, and D. H. Pincus. 1998. Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the United States. J. Clin. Microbiol. 36:1467.
15. Sebti, A., T. E. Kiehn, D. Perlin, V. Chaturvedi, M. Wong, A. Doney, S. Park, and K. A. Sepkowitz. 2001. Candida dubliniensis at a cancer center. Clin. Infect Dis. 32:1034-1038.
16. Sullivan, D. J., T. J. Westerneng, J. A. Haynes, D. E. Bennett, and D. C. Coleman. 1995. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidiosis in HIV-infected individuals. Microbiology 141(Pt. 7):1507-1521.
17. Sullivan, D., and D. Coleman. 1997. Candida dubliniensis: an emerging opportunistic pathogen. Curr. Top. Med. Mycol. 8:15-25.
18. Sullivan, D., and D. Coleman. 1998. Candida dubliniensis: characteristics and identification. J. Clin. Microbiol. 36:329-334.
19. Vargas, K. G., and S. Joly. 2002. Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals. J. Clin. Microbiol. 40: 341-350.
20. Vilela, M. M. S., K. Kamei, A. Sano, R. Tanaka, J. Uno, I. Takahashi, J. Ito, K. Yarita, and M. Miyaji. 2002. Pathogenicity and virulence of Candida dubliniensis: comparison with C. albicans. Med. Mycol. 40:249-257.